FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W764788035> ?p ?o ?g. }

• W764788035 endingPage "713.e2" @default.
• W764788035 startingPage "707" @default.
• W764788035 abstract "To assess whether there is a protective association between statin use and uveitis diagnosis.Retrospective, population-based case-control study.Medical records of all patients in the Kaiser Permanente Hawaii health plan between January 1, 2006 and December 31, 2007 (N = 217 061) were searched electronically for International Classification of Diseases, 9th Revision, diagnosis codes related to uveitis. Chart review was done to confirm incident uveitis diagnosis during the study period. Two control groups were each randomly selected at a 5:1 ratio to cases, and controls were assigned an index date to match their respective case diagnosis date. One control group was selected from the general Kaiser Permanente Hawaii population that had at least 1 healthcare visit during the study period. Another control group was selected from the population of Kaiser Permanente Hawaii members who had at least 1 visit to the ophthalmology clinic during the study period. Statin use was defined as filling a prescription for statin medication in the year prior to the diagnosis or index date based on an electronic search of the Kaiser Permanente Hawaii pharmacy database for Generic Product Identification codes. A conditional logistic regression model with clinical diagnosis of uveitis as the outcome was used to assess the relationship between statin use and uveitis.One hundred eight incident cases of uveitis were identified. Nineteen percent of uveitis patients had used statin medication in the year prior to diagnosis compared to 30% of patients in the general Kaiser population control (P = .03) and 38% of patients in the ophthalmology clinic control (P < .001). Using the general Kaiser population control and adjusting for age, sex, race, and autoimmune diseases, the odds of a statin user developing uveitis were 48% less than the odds of a non-statin user developing uveitis (OR: 0.52, 95% CI: 0.29-0.94, P = .03). Similarly, the odds of developing uveitis were 33% less for statin users compared to non-statin users (OR: 0.67, 95% CI: 0.38-1.19, P = .17) when adjusting for these factors and using the ophthalmology clinic control group.Statin use may be protective against the development of uveitis. Several anti-inflammatory and immunomodulatory mechanisms may explain this association." @default.
• W764788035 created "2016-06-24" @default.
• W764788035 creator A5055925749 @default.
• W764788035 creator A5062363829 @default.
• W764788035 creator A5073945118 @default.
• W764788035 creator A5078260329 @default.
• W764788035 creator A5086084914 @default.
• W764788035 creator A5091117608 @default.
• W764788035 date "2015-04-01" @default.
• W764788035 modified "2023-10-12" @default.
• W764788035 title "Association Between Statin Use and Uveitis: Results From the Pacific Ocular Inflammation Study" @default.
• W764788035 cites W1523693806 @default.
• W764788035 cites W1546258268 @default.
• W764788035 cites W1910601108 @default.
• W764788035 cites W1966564237 @default.
• W764788035 cites W1968276329 @default.
• W764788035 cites W1968620704 @default.
• W764788035 cites W1970036264 @default.
• W764788035 cites W1973459017 @default.
• W764788035 cites W1981986974 @default.
• W764788035 cites W1988191877 @default.
• W764788035 cites W1991583073 @default.
• W764788035 cites W2005929902 @default.
• W764788035 cites W2007954685 @default.
• W764788035 cites W2011139656 @default.
• W764788035 cites W2021883141 @default.
• W764788035 cites W2026152618 @default.
• W764788035 cites W2037269612 @default.
• W764788035 cites W2038799861 @default.
• W764788035 cites W2053854676 @default.
• W764788035 cites W2066560916 @default.
• W764788035 cites W2073741050 @default.
• W764788035 cites W2088410052 @default.
• W764788035 cites W2092817423 @default.
• W764788035 cites W2092884005 @default.
• W764788035 cites W2103636227 @default.
• W764788035 cites W2106036809 @default.
• W764788035 cites W2106689652 @default.
• W764788035 cites W2107986169 @default.
• W764788035 cites W2108438601 @default.
• W764788035 cites W2111234909 @default.
• W764788035 cites W2111419779 @default.
• W764788035 cites W2113082270 @default.
• W764788035 cites W2119021779 @default.
• W764788035 cites W2125589683 @default.
• W764788035 cites W2129750583 @default.
• W764788035 cites W2130463133 @default.
• W764788035 cites W2130504616 @default.
• W764788035 cites W2138220081 @default.
• W764788035 cites W2147912194 @default.
• W764788035 cites W2150117087 @default.
• W764788035 cites W2153390391 @default.
• W764788035 cites W2156434735 @default.
• W764788035 cites W2165674014 @default.
• W764788035 cites W2167734104 @default.
• W764788035 cites W2168911347 @default.
• W764788035 cites W2247997571 @default.
• W764788035 cites W2419271990 @default.
• W764788035 cites W256976557 @default.
• W764788035 doi "https://doi.org/10.1016/j.ajo.2015.01.009" @default.
• W764788035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25597838" @default.
• W764788035 hasPublicationYear "2015" @default.
• W764788035 type Work @default.
• W764788035 sameAs 764788035 @default.
• W764788035 citedByCount "21" @default.
• W764788035 countsByYear W7647880352016 @default.
• W764788035 countsByYear W7647880352017 @default.
• W764788035 countsByYear W7647880352018 @default.
• W764788035 countsByYear W7647880352019 @default.
• W764788035 countsByYear W7647880352020 @default.
• W764788035 countsByYear W7647880352021 @default.
• W764788035 countsByYear W7647880352023 @default.
• W764788035 crossrefType "journal-article" @default.
• W764788035 hasAuthorship W764788035A5055925749 @default.
• W764788035 hasAuthorship W764788035A5062363829 @default.
• W764788035 hasAuthorship W764788035A5073945118 @default.
• W764788035 hasAuthorship W764788035A5078260329 @default.
• W764788035 hasAuthorship W764788035A5086084914 @default.
• W764788035 hasAuthorship W764788035A5091117608 @default.
• W764788035 hasBestOaLocation W7647880352 @default.
• W764788035 hasConcept C104863432 @default.
• W764788035 hasConcept C118487528 @default.
• W764788035 hasConcept C126322002 @default.
• W764788035 hasConcept C151956035 @default.
• W764788035 hasConcept C167135981 @default.
• W764788035 hasConcept C187212893 @default.
• W764788035 hasConcept C194828623 @default.
• W764788035 hasConcept C195910791 @default.
• W764788035 hasConcept C2426938 @default.
• W764788035 hasConcept C2776194053 @default.
• W764788035 hasConcept C2776839432 @default.
• W764788035 hasConcept C2908647359 @default.
• W764788035 hasConcept C45827449 @default.
• W764788035 hasConcept C512399662 @default.
• W764788035 hasConcept C71924100 @default.
• W764788035 hasConcept C98274493 @default.
• W764788035 hasConcept C99454951 @default.
• W764788035 hasConceptScore W764788035C104863432 @default.

• next